Tag Archives: pharmaceutical industry

Ketamine for Depression: Research versus Marketing

This post is a part of our Bioethics in the News series By Arthur Ward, PhD Just weeks ago, the U.S. Food and Drug Administration approved Ketamine as the first new drug in decades for treatment of depression. Or rather, while the … Continue reading

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , , , , | 2 Comments

Botox for Millennials?

This post is a part of our Bioethics in the News series By Devan Stahl, PhD When I was in my mid-twenties I went to my physician to have a mole on my face removed. Before my dermatologist began the procedure, however, … Continue reading

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , , , , | 2 Comments

Web of Interests Surrounding Medicines Makes Patient Access Increasingly Difficult

This post is a part of our Bioethics in the News series By Jennifer Carter-Johnson, PhD, JD A recent New York Times article described the problems that patients are having gaining access to a new class of cholesterol reducers, called PCSK9 … Continue reading

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , , , | 13 Comments

“Ask your doctor” – or just check Instagram?

This post is a part of our Bioethics in the News series By Robyn Bluhm, PhD A couple of months ago, Kim Kardashian posted – and then quickly deleted – and then reposted – an Instagram advertisement promoting a morning sickness … Continue reading

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , , , , , | 2 Comments

Dr. Cabrera and team published in ‘Neurosurgical Focus’

Center Assistant Professor Dr. Laura Cabrera and co-authors Hayden M. K. Boyce, MD, Rachel McKenzie, and Robyn Bluhm, PhD, have an article in the August 2018 issue of Neurosurgical Focus. “Conflicts of interest and industry professional relationships in psychiatric neurosurgery: a … Continue reading

Posted in Articles, Publications, Research, Uncategorized | Tagged , , , , , , , , ,

Greed Is God: The Divine Right to Avaricious Drug Pricing

This post is a part of our Bioethics in the News series By Leonard M. Fleck, PhD Some recent headlines worth noting: “U.S. Prescription Drug Costs Are a Crime,” “Americans Say They are Suffering as Drug Costs Continue to Rise,” “When … Continue reading

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , , ,

Dr. Fleck presents at Michigan State Medical Society Conference on Bioethics

Center Professor Dr. Len Fleck presented at the 20th Annual Michigan State Medical Society Conference on Bioethics, held on November 12, 2016 in Ann Arbor. The theme of the conference was “Ethical Issues in the Pharmaceutical Industry: Current Controversies and … Continue reading

Posted in Bioethics Events, Center News, Friends of the Center, Research, Uncategorized | Tagged , , , , ,